How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

229 results for

Microdermabrasion

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

21. Study to Evaluate Efficacy and Tolerability of Two Topical Regimens in Subjects With Moderate to Severe Facial Photodamage Who Have Received Cosmetic Injections

self-tanners, on their face for the duration of the study other than make-up with an established tolerance of at least 1 month. Willingness to withhold all facial treatments during the course of the study including microdermabrasion, peels, facials, laser treatments and tightening treatments. .Willingness to avoid as much as possible, direct and prolonged sun exposure for the duration of the study (including tanning beds), especially from 10 AM to 2 PM. Subjects are asked to wear protective

2018 Clinical Trials

22. Evaluation of BTX 1503 in Patients With Moderate to Severe Acne Vulgaris

had facial procedures (chemical or laser peel, microdermabrasion, etc.) within 8 weeks (56 days) prior to the Baseline Visit. Subject has had treatment with systemic antibiotics within 4 weeks (28 days) prior to the Baseline Visit. Subject has had treatment with systemic anti-acne drugs within 4 weeks (28 days) prior to the Baseline Visit. Subject has had treatment with systemic anti-inflammatory drugs within 4 weeks (28 days) prior to the Baseline Visit. Subject has had treatment with systemic

2018 Clinical Trials

23. Evaluation of the Ulthera® System and Efficacy Correlation to Morphological Differences

. Excessive skin laxity on the area(s) to be treated. Significant scarring in the area(s) to be treated that would interfere with assessing results. Open wounds or lesions in the area(s) to be treated. Severe or cystic acne on the area(s) to be treated. Active implants (e.g., pacemakers or defibrillators), or metallic implants in the treatment areas (dental implants not included.) Inability to understand the protocol or to give informed consent. Microdermabrasion, or prescription level glycolic acid

2018 Clinical Trials

24. Imaging of Pilosebaceous Units and Acne Lesions by RCM and OCT Confocal Microscopy and Optical Coherence Tomography

in the areas Subject having used oral retionoid therapy such as isotretionoin within 3 months prior to baseline. Subject having used topical retinoids, topical corticosteroids, topical antibiotics or combination therapy within 2 weeks of baseline Subject having used over-the-counter topical products containing azelaic acid, benzoyl peroxide, and/or salicylic acid within 1 week of baseline Subject having used light treatments including Intense Pulsed Light or other lasers, microdermabrasion or chemical

2018 Clinical Trials

25. Secret Micro-Needle Fractional RF System® for the Treatment of Facial Wrinkles

the last 3 months A subject with a history of previous fat transfer, injectable calcium hydroxylapatite or poly-l-lactic acid to the study area within the past 6 months. A subject with a history of injection of hyaluronic acid dermal fillers in the study area within the past six months. Retinoid, hydroquinone, microdermabrasion, or chemical peel treatments to the face within one month prior to study participation or during the study. Current participation or participation within 30 days prior

2018 Clinical Trials

26. Dynamic Optical Coherence Tomography(D-OCT) Aging Study: A Preliminary Evaluation of Structural Differences Between Young and Aged Skin, Cellulite and Atrophic Acne Scars in Female Caucasian Subjects With Fitzpatrick Skin Types I-III Utilizing Non-invasiv

. These include products that address skin imperfections. This does not include a basic cleanser, moisturizer and sunscreen.(time frame 2 weeks) Chemical peel, microdermabrasion, dermaplaning, or microneedling (time frame 3 months) Retin-A®, Retin-A Micro®, Renova®, Avita®, Tazorac®, Avage® or Differin® or other similar prescription drugs (time frame 3 months) Cosmetic injections (filler and/or toxins, i.e. Juvederm, Radiesse, Botox, etc.), non-ablative laser or fractional laser resurfacing (time frame 12

2018 Clinical Trials

28. Comparison of Physical Pretreatment Regimens to Enhance Protoporphyrin IX Uptake in Photodynamic Therapy: A Randomized Clinical Trial. (Abstract)

November 28 to December 20, 2014, at Bispebjerg Hospital, Copenhagen, Denmark, among 12 healthy volunteers 18 years or older. Analysis was based on intention to treat. All participants completed the study protocol.Participants were each exposed to standardized skin preparation with curettage, microdermabrasion with abrasive pads, microneedling with dermarollers, ablative fractional laser (AFXL), non-AFXL, and no pretreatment, followed by 3 hours of methyl aminolevulinate hydrochloride incubation (...) with partial removal of the stratum corneum after curettage and microdermabrasion and similar vertical penetration depths for microneedling, AFXL, and non-AFXL (median, 125 μm). PPIX fluorescence reached highest intensities in skin pretreated with AFXL (median, 8661 arbitrary units [AU]) compared with microdermabrasion (median, 6731 AU), microneedling (median, 5609 AU), and curettage (median, 4765 AU) (P < .001), among which similar enhancement was shown. Comparatively lower fluorescence levels were

2017 JAMA dermatology (Chicago, Ill.) Controlled trial quality: predicted high

29. The Combination Therapy of Fractional Laser and PRP Compared With Nanofat Grafting and PRP Synergy in Treating Striae Gravidarum.

, microdermabrasion, platelet-rich plasma injection(PRP), etc. To some extent, these treatments can improve striae gravidarum. In this clinical trial, the investigators are going to treat striae gravidarum by using two different kinds of combination therapies. One is fractional laser and PRP injection synergy, and the other one is treated by nanofat grafting with PRP injection. Condition or disease Intervention/treatment Phase Treatments of Striae Gravidarum Device: Fractional CO2 Laser Procedure: Nanofat

2017 Clinical Trials

30. Study to Assess the Cosmetic Changes in the Facial Skin After Use of a Topical Retinoid Product in Participants With Moderate to Severe Photodamage

, rosacea, skin cancer, etc.) Individuals who require electrolysis, waxing, or use depilatories on the face during the study Chemical peel or microdermabrasion within 4 weeks of study start Retin-A®, Retin-A Micro®, Renova®, Avita®,Tazorac®, Avage® or Differin® or other similar prescription drugs within 3 months of study start Cosmetic injections (filler and/or toxins, i.e. Juvederm, Radiesse, Botox, etc.), non-ablative laser or fractional laser resurfacing Accutane® or other oral retinoid, Ablative

2017 Clinical Trials

31. A Phase 2 Safety and Efficacy Study of UHE-101 Cream in Subjects With Acne Vulgaris

, and salicylic acid within two weeks of Baseline; Topical retinoids (e.g., tazarotene, adapalene, and tretinoin) within four weeks of Baseline; Light treatments, microdermabrasion, or chemical peels within eight weeks of Baseline; Other topical therapy, which may materially affect the patient's acne, in the investigator's opinion. Patient has used any of the following systemic anti-acne medications: Corticosteroids (including intramuscular and intralesional injections) within four weeks of Baseline. Inhaled

2017 Clinical Trials

32. Open-label, Prospective Evaluation of the Ulthera® System for Lifting Submental (Under the Chin) and Neck Tissue in Chinese Patients

that would interfere with assessing results. Open wounds or lesions in the area(s) to be treated. Severe or cystic acne on the area(s) to be treated. Active implants (e.g., pacemakers or defibrillators), or metallic implants in the treatment areas (dental implants not included.) Inability to understand the protocol or to give informed consent. Allergy or sensitivity to pre-treatment medication (ibuprofen). Microdermabrasion, or prescription level glycolic acid treatment to the treatment area(s) within

2017 Clinical Trials

33. General quality of life of patients with acne vulgaris before and after performing selected cosmetological treatments Full Text available with Trip Pro

. In the study group, the acne changes occurred over the course of 3-15 years ([Formula: see text] years, SD =2.7 years). Selected cosmetological treatments (intensive pulsing light, alpha-hydroxy acids, cavitation peeling, needle-free mesotherapy, diamond microdermabrasion and sonophoresis) were performed in series in the number depending on the particular patient's chosen treatment, after excluding contraindications. General quality of life of the patients was estimated using the Skindex-29 and Dermatology

2017 Patient preference and adherence

34. PRO With Luxerm® in the Field Treatment of Thin and Non-hyperkeratotic Non-pigmented AK

of initiation of treatment. Subject with a wash-out period from baseline for topical or systemic treatment or medical/surgical procedure in the anatomical area (for AKs) less than the following: Retinoids, including tazarotene, adapalene, tretinoin, retinol ==> 4 weeks Cryotherapy, diclofenac, corticosteroids or other treatments for AK==> 8 weeks Microdermabrasion, laser ablative treatments or chemical peels ==>8 weeks 5-FU, imiquimod ==>24 weeks Surgical: excision and reconstructive surgery, chemosurgery

2017 Clinical Trials

35. Open Label Phase 2 Feasibility Study of BPX-04 Topical Minocycline Gel in Rosacea

of rosacea within 4 weeks prior to baseline. Have used prescription topical (on the face) or oral antibiotics or corticosteroids within 4 weeks prior to baseline. Have had a facial procedure such as chemical peel, laser, microdermabrasion within 8 weeks prior to baseline Have received photodynamic therapy or phototherapy with blue or red light within 12 weeks prior to baseline Have used an oral retinoid within 6 months or a topical retinoid within 3 months prior to baseline Current drug or alcohol abuse

2017 Clinical Trials

36. Photodynamic Therapy Incubation Times for Actinic Keratosis

treatments within the past 6 months. Use of keratolytics within 2 days of initiation of treatment (e.g., >5% urea, glycolic acid, lactic acid, salicyclic acid) Cryotherapy within the past 2 weeks. Topical retinoids within the past 4 weeks Procedures, such as microdermabrasion, ablative lasers, ALA-PDT, chemical peels, 5-fluorouraci, diclofenac, imiquimod within the past 8 weeks Systemic retinoids within the past 6 months Pregnant or breast feeding Uncooperative subjects or subjects with neurological

2017 Clinical Trials

37. A Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris

or vitamin A supplements greater than 10,000 units/day within 6 months prior to Baseline Facial procedures (chemical or laser peel, microdermabrasion, etc.) within the past 8 weeks Contacts and Locations Go to Information from the National Library of Medicine To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor. Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03028363 Sponsors

2017 Clinical Trials

38. Phase 3 Study of Levulan With New Blue Light for AK on the Face or Scalp

: Keratolytics including urea (greater than 5%), alpha hydroxyacids [e.g.glycolic acid, lactic acid, etc. greater than 5%], salicylic acid (greater than 2%) within 2 days of initiation of treatment. Curettage or Cryotherapy within 2 weeks of initiation of treatment Retinoids, including tazarotene, adapalene, tretinoin, within 4 weeks of initiation of treatment. Microdermabrasion, laser ablative treatments, ALA-PDT, chemical peels, 5-FU, diclofenac, ingenol mebutate, imiquimod or other topical treatments

2017 Clinical Trials

39. Evaluation of the Cosmetic Benefit of a Skin Cream in Healthy Females With Mild to Advanced Photo-damaged Facial Skin Who Have Undergone a Glycolic Acid Facial Peel Procedure

) Aesthetic, cosmetic or dermatological treatment in the treatment area (face), including the use of skin tone lightning products, within the last 3 months, t) Use of facial scrubs, depilatory creams, waxing and/or bleaching within the last 2 weeks prior to screening, u) Microdermabrasion and/or laser hair removal within the last 4 weeks prior to screening, and v) Medical history of Herpes Simplex (Cold Sores). a) Known or suspected intolerance or hypersensitivity to the study materials (or closely

2017 Clinical Trials

40. A Randomized, Vehicle-Controlled Study of 2 Concentrations of A-101 for the Treatment of Seborrheic Keratosis

assessments: LASER, light or other energy based therapy (e.g., intense pulsed light [IPL], photo-dynamic therapy [PDT]; 180 days Liquid nitrogen, electrodesiccation, curettage, imiquimod, 5-FU, or ingenol mebutate; 60 days Hydrogen peroxide: 90 days Retinoids; 28 days Microdermabrasion or superficial chemical peels; 14 days Corticosteroids or antibiotics; 14 days Subject would require the use of any topical treatment (e.g. moisturizers, sunscreen) to any of the Target Lesions 12 hours prior to any study

2017 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>